Novoprotein Scientific Inc. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 110.71 million compared to CNY 212.63 million a year ago. Revenue was CNY 110.71 million compared to CNY 212.63 million a year ago.

Net income was CNY 15.88 million compared to CNY 90.11 million a year ago. Basic earnings per share from continuing operations was CNY 0.2262 compared to CNY 1.71 a year ago. Diluted earnings per share from continuing operations was CNY 0.2262 compared to CNY 1.71 a year ago.